| 专利名称 | THERAPEUTIC USE OF AFATINIB IN CANCER | ||
| 申请号 | EP18382527 | 申请日 | |
| 公开（公告）号 | EP3597193A1 | 公开（公告）日 | |
| 申请（专利权）人 | Universitat Aut騨oma de Barcelona; Consorcio Centro de Investigaci髇 Biom閐ica en Red M P; Fundacio Institut de Recerca de l' Hospital de la Santa Creu i sant Pau | 发明人 | Surrall閟 Calonge Jordi; Minguill髇 Pedre駉 Jordi; Montanuy Escribano Helena |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
The present invention provides the afatinib or a pharmaceutically salt thereof for use in the treatment and/or prevention of a cancer in a patient suffering from a disease caused by a defect in DNA damage repair mechanism.Surprisingly, when afatinib was administered to FA cells, it was confirmed that there was a therapeutic anti-cancer effect without any toxic side-effect on DNA. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
